These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35976467)

  • 1. Low-intensity red-light therapy in slowing myopic progression and the rebound effect after its cessation in Chinese children: a randomized controlled trial.
    Chen H; Wang W; Liao Y; Zhou W; Li Q; Wang J; Tang J; Pei Y; Wang X
    Graefes Arch Clin Exp Ophthalmol; 2023 Feb; 261(2):575-584. PubMed ID: 35976467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Power Red Laser Treatment for Anisometropic Myopia Control in Children: A Contralateral Comparison Study.
    Wang Y; Li X; Abudukeyimu K; Du W; Ning Y; Qi X; Hua N; Wei N; Ding G; Li J; Song L; Zhang Y; Qian X
    Discov Med; 2023 Feb; 35(174):11-18. PubMed ID: 37024437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained and rebound effect of repeated low-level red-light therapy on myopia control: A 2-year post-trial follow-up study.
    Xiong R; Zhu Z; Jiang Y; Kong X; Zhang J; Wang W; Kiburg K; Yuan Y; Chen Y; Zhang S; Xuan M; Zeng J; Morgan IG; He M
    Clin Exp Ophthalmol; 2022 Dec; 50(9):1013-1024. PubMed ID: 36054314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Different Powers of Low-Level Red Light in Children for Myopia Control.
    Zhou W; Liao Y; Wang W; Sun Y; Li Q; Liu S; Tang J; Li L; Wang X
    Ophthalmology; 2024 Jan; 131(1):48-57. PubMed ID: 37634757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of low-level red light for controlling progression of Myopia in children and adolescents.
    Xiong Y; Liao Y; Zhou W; Sun Y; Zhu M; Wang X
    Photodiagnosis Photodyn Ther; 2024 Oct; 49():104267. PubMed ID: 39009205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children: A Randomized, Double-Blind, Controlled Clinical Trial.
    Dong J; Zhu Z; Xu H; He M
    Ophthalmology; 2023 Feb; 130(2):198-204. PubMed ID: 36049646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-intensity, long-wavelength red light slows the progression of myopia in children: an Eastern China-based cohort.
    Zhou L; Xing C; Qiang W; Hua C; Tong L
    Ophthalmic Physiol Opt; 2022 Mar; 42(2):335-344. PubMed ID: 34981548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of wearing dual-focus soft contact lenses on myopia progression: a one-year randomized clinical trial in Chinese school-age children.
    Chen Y; Yang B; Kou J; Liu L
    BMC Ophthalmol; 2024 Sep; 24(1):426. PubMed ID: 39350093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Repeated Low-Level Red Light (RLRL) therapy on myopia outcomes in children: a systematic review and meta-analysis.
    Youssef MA; Shehata AR; Adly AM; Ahmed MR; Abo-Bakr HF; Fawzy RM; Gouda AT
    BMC Ophthalmol; 2024 Feb; 24(1):78. PubMed ID: 38378527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the myopia progression control efficacy of defocus incorporated multiple segments (DIMS) lenses and Apollo progressive addition spectacle lenses (PALs) in 6- to 12-year-old children: study protocol for a prospective, multicenter, randomized controlled trial.
    Li Y; Fu Y; Wang K; Liu Z; Shi X; Zhao M
    Trials; 2020 Mar; 21(1):279. PubMed ID: 32188478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Changes and Predictive Value of Choroidal Thickness for Myopia Control after Repeated Low-Level Red-Light Therapy.
    Xiong R; Zhu Z; Jiang Y; Wang W; Zhang J; Chen Y; Bulloch G; Yuan Y; Zhang S; Xuan M; Zeng J; He M
    Ophthalmology; 2023 Mar; 130(3):286-296. PubMed ID: 36240954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in subfoveal choroidal thickness secondary to orthokeratology and its cessation: a predictor for the change in axial length.
    Li Z; Hu Y; Cui D; Long W; He M; Yang X
    Acta Ophthalmol; 2019 May; 97(3):e454-e459. PubMed ID: 30288939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
    Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
    Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence.
    Zhou L; Tong L; Li Y; Williams BT; Qiu K
    Sci Rep; 2023 Feb; 13(1):3321. PubMed ID: 36849626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children: A Multicenter Randomized Controlled Trial.
    Jiang Y; Zhu Z; Tan X; Kong X; Zhong H; Zhang J; Xiong R; Yuan Y; Zeng J; Morgan IG; He M
    Ophthalmology; 2022 May; 129(5):509-519. PubMed ID: 34863776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
    JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety.
    Hansen NC; Hvid-Hansen A; Møller F; Bek T; Larsen DA; Jacobsen N; Kessel L
    BMC Ophthalmol; 2023 Oct; 23(1):438. PubMed ID: 37904082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rebound Effect in the Misight Assessment Study Spain (Mass).
    Ruiz-Pomeda A; Prieto-Garrido FL; Hernández Verdejo JL; Villa-Collar C
    Curr Eye Res; 2021 Aug; 46(8):1223-1226. PubMed ID: 33460537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions to slow progression of myopia in children.
    Walline JJ; Lindsley KB; Vedula SS; Cotter SA; Mutti DO; Ng SM; Twelker JD
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004916. PubMed ID: 31930781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of myopic rebound effect after discontinuation of treatment with 0.01% atropine eye drops in Japanese school-age children.
    Hieda O; Hiraoka T; Fujikado T; Ishiko S; Hasebe S; Torii H; Takahashi H; Tanaka S; Kinoshita S;
    Jpn J Ophthalmol; 2023 Sep; 67(5):602-611. PubMed ID: 37548816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.